Is the tiered immunogenicity testing of biologics the adequate approach in preclinical development?

被引：0
|
作者：
Sauerborn, Melody [1 ]
机构：
[1] TNO Triskel, Dept Bioanal, NL-3704 HE Zeist, Netherlands
来源：
BIOANALYSIS | 2013年 / 5卷 / 07期
关键词：
anti-drug antibodies; biologics; immunoassays; immunogenicity; risk-based assessment; tiered approach; ANTIBODIES; ASSAYS;
D O I：
10.4155/BIO.13.43
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：743 / 746
页数：4
相关论文
共 50 条
  • [31] Development of a high throughput assay for use in preclinical testing
    Dertinger, S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (07) : 539 - 539
  • [32] An Approach for Iteratively Generating Adequate Tests in Metamorphic Testing: A Case Study
    Ding, Junhua
    Zhang, Dongmei
    PROCEEDINGS 2016 IEEE 40TH ANNUAL COMPUTER SOFTWARE AND APPLICATIONS CONFERENCE WORKSHOPS, VOL 1, 2016, : 263 - 268
  • [33] Bioanalysis of chiral compounds during drug development using a tiered approach
    Jian, Wenying
    Edom, Richard W.
    Huang, Mike
    Weng, Naidong
    BIOANALYSIS, 2014, 6 (05) : 629 - 639
  • [34] A Multi-Tiered Approach to Evaluating a Nonformal Youth Development Program
    Walahoski, Jill
    Le Menestrel, Suzanne
    JOURNAL OF YOUTH DEVELOPMENT, 2012, 7 (02): : 76 - 81
  • [35] A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: Eye irritation
    McNamee, Pauline
    Hibatallah, Jalila
    Costabel-Farkas, Margit
    Goebel, Carsten
    Araki, Daisuke
    Dufour, Eric
    Hewitt, Nicola J.
    Jones, Penny
    Kirst, Annette
    Le Varlet, Beatrice
    Macfarlane, Martin
    Marrec-Fairley, Monique
    Rowland, Joanna
    Schellauf, Florian
    Scheel, Julia
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2009, 54 (02) : 197 - 209
  • [36] Screening for endocrine disruptors in product development: Tiered testing using in vitro and in vivo assays
    Kolle, S.
    Buesen, R.
    Kamp, H.
    Landsiedel, R.
    van Ravenzwaay, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 88 - 88
  • [37] Abuse liability assessment in preclinical drug development: Predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models
    Teuns, Greet B. A.
    Geys, Helena M.
    Geuens, Sonja M. A.
    Stinissen, Piet
    Meert, Theo F.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2014, 70 (03) : 295 - 309
  • [38] Development and Preclinical Testing of a Miniaturized Implantable Ventricular Assist Device
    Arndt, A.
    Graichen, K.
    Mueller, J.
    Erd, L.
    Krambeck, H.
    Goellner, M.
    Nuesser, P.
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2012, 57 : 26 - 26
  • [39] CRITERIA FOR THE FORMULATION OF AN ADEQUATE APPROACH IN AIDING THE DEVELOPMENT OF UNDERDEVELOPED AREAS
    Niebyl, Karl H.
    CANADIAN JOURNAL OF ECONOMICS & POLITICAL SCIENCE, 1952, 18 (03): : 365 - 371
  • [40] Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
    Govindarajan, Dhanasekaran
    Meschino, Steven
    Guan, Liming
    Clements, David E.
    ter Meulenc, Jan H.
    Casimiro, Danilo R.
    Collera, Beth-Ann G.
    Bett, Andrew J.
    VACCINE, 2015, 33 (33) : 4105 - 4116
12345